<DOC>
	<DOCNO>NCT01689441</DOCNO>
	<brief_summary>Observational study among critically ill patient show strong association vitamin D deficiency adverse outcome , include increased length stay , infection , mortality . It unknown whether vitamin D deficiency contribute directly adverse outcome whether simply biomarker severity illness overall health status . However , vitamin D play key role host defense , largely stimulate production anti-microbial peptide cathelicidin ( LL-37 ) . We test hypothesis administration activate vitamin D ( calcitriol ) increase serum level cathelicidin .</brief_summary>
	<brief_title>Randomized Controlled Trial Calcitriol v . Placebo Among Critically-ill Patients With Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>age ≥ 18 Severe sepsis septic shock Central venous catheter ( blood draw ) Serum calcium ≥ 10.0 mg/dl phosphate ≥ 6.0 mg/dl , assess within previous 48 hour Current recent therapy ( within previous 7 day ) nutritional vitamin D dose &gt; 1,000 I.U . per day activate vitamin D dose History solid organ bone marrow transplant , primary parathyroid disease , metabolic bone disease , sarcoidosis Expected die leave ICU within 48 hour History hypersensitivity allergic reaction calcitriol End stage renal disease Acute Kidney Injury receive intermittent renal replacement therapy Enrolled compete study Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>